Global Cardiac Rhythm Management Devices Market Outlook 2022

Cardiac rhythm management devices continue to evolve rapidly in form factor, reliability and lifespan. Even as implantable designs become increasingly compact and functional, they are introducing groundbreaking new elements like leadless pacing and integrated fixation concepts for minimally invasive deployment. Cardiac rhythm management devices such as pacemakers, implantable cardiac defibrillators (ICDs) and CRT devices are all getting smaller, smarter and longer-lasting.
Rise in cholesterol levels, hypertension, and excessive smoking lead to high risks of cardiac disorders, resulting in the growing need for cardiovascular therapeutic instruments such as CRT devices. Governments and organizations in many countries implement various initiatives to educate and help people to make medical decisions, increase public awareness, and improve the quality of life. Pacemakers, ICDs, and CRT devices are used to treat arrhythmias and are considered as a standard treatment option in many countries.       

The global Cardiac Rhythm Management Devices market was valued at US$ 11190 million in 2020 and is expected to reach US$ 15280 million by the end of 2027, growing at a CAGR of 4.5% during 2021-2027.
This report focuses on Cardiac Rhythm Management Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cardiac Rhythm Management Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Cardiac Rhythm Management Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Implantable Defibrillators
Bi Ventricular Pacemakers

Segment by Application
Hospitals
Clinics
Home Settings
ASC

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Boston Scientific
Medtronic
Abbott
Altera
Biotronik